Kahn named medical director of radiation oncology at Winship at Emory Saint Joseph's Hospital
Aug. 28, 2017
Media Contact »
Mary Beth Spence
Senior Manager, Media Relations
Winship Cancer Institute has named Shannon Kahn, MD, medical director of radiation oncology at Emory Saint Joseph's Hospital. A board certified radiation oncologist, Kahn joined the Winship staff at Emory Saint Joseph's five years ago and specializes in the treatment of patients with malignant and benign brain tumors, breast and lung cancers.
She is skilled at Gamma Knife radiosurgery, a minimally invasive radiation treatment for malignant and nonmalignant tumors, trigeminal neuralgia (facial pain syndrome), and other neurological disorders. Emory Saint Joseph's is the first hospital in the state and one of only seven medical centers in the nation to offer advanced radiosurgery for the brain with the Gamma Knife® Icon.
"Shannon is an extraordinary physician and has already established herself as a great leader at Winship at Emory Saint Joseph's Hospital. I look forward to working even more closely with Shannon so that all patients enjoy the advantages of the expertise of our NCI-designated comprehensive cancer center team in a community environment," says Winship Executive Director Walter J. Curran, Jr., MD.
Prior to her career in medicine, Kahn earned her Bachelor of Science in Business Administration and a Master in Accountancy at the University of North Carolina at Chapel Hill and worked for Arthur Andersen as a certified public accountant and financial auditor. When her mother was diagnosed with breast cancer, Kahn decided to pursue a career in medicine. She earned her degree from the Emory University School of Medicine, completing her internship in internal medicine and residency in radiation oncology at Emory University.
Kahn has authored and co-authored several presentations at national research and healthcare meetings and many publications in national and international peer-reviewed journals. She has published on the use of radiotherapy for patients with Hodgkin's and non-Hodgkin's lymphoma, the effectiveness and side-effect profile of radiotherapy in the treatment of prostate cancer, and the use of alternative treatment modalities for long-term treatment sequelae among patients with head and neck cancer.
Kahn is a clinical member of Winship's Cancer Prevention and Control Research Program. Her society memberships include the American Medical Association, the American Society of Therapeutic Radiology and Oncology, and the American Society of Clinical Oncology.
Winship at Emory Saint Joseph's offers patients cutting edge treatment and access to clinical trials in their own community. Winship is Georgia's first and only National Cancer Institute (NCI)-Designated Comprehensive Cancer Center. This elite NCI designation means that Winship is reducing the cancer burden in Georgia through research in its laboratories, clinical trials, and population-based science, providing Georgians improved access to clinical trials and resources available only at select cancer centers.